We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

bioMérieux

Designs, develops, manufactures and markets in vitro diagnostics systems used in clinical and industrial applications read more Featured Products: More products

Download Mobile App





bioMérieux Showcases Advanced Generation of VIDAS Immunoassay Solution

By LabMedica International staff writers
Posted on 05 Feb 2024
Print article
Image: The VIDAS KUBE next generation system in the VIDAS immunoassay portfolio is highlighted at Medlab Middle East 2024 (Photo courtesy of bioMérieux)
Image: The VIDAS KUBE next generation system in the VIDAS immunoassay portfolio is highlighted at Medlab Middle East 2024 (Photo courtesy of bioMérieux)

bioMérieux (Marcy l'Etoile, France) is participating in Medlab Middle East 2024 as a Diamond Partner where the company is sharing its game-changing innovations. Visitors to the bioMérieux booth can discover, and exchange insights on antimicrobial stewardship, sepsis management, point-of-care solutions, and emergency care, among others.

At Medlab Middle East 2024, bioMérieux is presenting its recently launched VIDAS KUBE, the advanced generation of its VIDAS immunoassay solution which has been trusted by labs around the world for more than 30 years. VIDAS has transformed the field of immunoassays offering laboratories universal access to a simple, automated, and robust technology providing fast and reliable results. Featuring a single-test concept in an all-in-one kit, VIDAS is currently used in more than 160 countries by 25,000 laboratories. It is still one of the most widely used immunoassay systems in clinical laboratories worldwide. VIDAS KUBE, the latest addition to this innovative range, combines advanced technology with the recognized values of the VIDAS solution. The new VIDAS KUBE features a stackable and modular benchtop design and easy implementation that will benefit clinical diagnostic labs. It is compatible with the existing broad routine test menu covering emergency and critical care, immunochemistry, and infectious diseases.

In addition, bioMérieux is showcasing VITEK MS PRIME, a next-level automated MALDI-TOF Mass Spectrometry system that enables accurate microbial identification to the species level. This benchtop high-throughput automated identification system has a robust database, which includes intra-species diversity, and delivers fast and confident microbial identification. The system has the features required to ensure compliance, and you can rely on our validation experts to implement this solution quickly and efficiently. bioMérieux is also highlighting the VITEK REVEAL rapid Antimicrobial Susceptibility Testing, integrated into its Sepsis Solution to help better manage bloodstream infections. Among its point-of-care diagnostic solutions, bioMérieux is highlighting the BIOFIRE SPOTFIRE System which is the latest advancement in molecular infectious disease diagnostics. All of the company’s expertise and cutting-edge FILMARRAY technology are at the heart of the system design. Within its point-of-care respiratory testing solutions, bioMérieux is spotlighting the BIOFIRE SPOTFIRE Respiratory Panels which offer rapid syndromic PCR tests for a range of common pathogens.

Related Links:
bioMérieux 

New
Gold Member
Strep Pneumoniae Rapid Test
Strep Pneumoniae (6503 – 6573)
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
New
Moxifloxacin Resistance Assay
Allplex MG & MoxiR Assay
New
H-FABP Test
Finecare H-FABP Rapid Quantitative Test

Print article

Channels

Molecular Diagnostics

view channel
Image: The kit includes a container with a film, a compact optical device for attaching a smartphone, and a diagnostic app (Photo courtesy of KIST)

Urine-Based Bladder Cancer Diagnostic Kit to Reduce Need for Unnecessary Cystoscopies

Bladder cancer has a high cure rate of over 90% when detected early, but it is characterized by a recurrence rate of 70%, which requires continuous monitoring. Late-stage detection often results in major... Read more

Microbiology

view channel
Image: The QIAstat-Dx mini gastrointestinal panel has secured U.S. clearance to support year-round outpatient care (Photo courtesy of QIAGEN)

Syndromic Panel Provides Fast Answers for Outpatient Diagnosis of Gastrointestinal Conditions

Acute infectious gastroenteritis is a major cause of outpatient visits and hospitalizations in the U.S., with over 179 million cases estimated annually. Now, a new gastrointestinal panel designed to provide... Read more

Pathology

view channel
Image: The AI tool can search through data and histology images for much more precise information on cancer treatment effectiveness (Photo courtesy of Shutterstock)

AI Tool Analyzes 30K Data Points Per Medical Imaging Pixel in Cancer Search

A new artificial intelligence (AI)-powered tool can detect cell-level characteristics of cancer by analyzing data from very small tissue samples, some as tiny as 400 square micrometers, equivalent to the... Read more

Technology

view channel
Image: Human tear film protein sampling methods (Photo courtesy of Clinical Proteomics. 2024 Mar 13;21:23. doi: 10.1186/s12014-024-09475-8)

New Lens Method Analyzes Tears for Early Disease Detection

Bodily fluids, including tears and saliva, carry proteins that are released from different parts of the body. The presence of specific proteins in these biofluids can be a sign of health issues.... Read more

Industry

view channel
Image: The game-changing immunoassay diagnostics platform delivers results from whole blood sample in 10 minutes (Photo courtesy of SpinChip)

bioMérieux Acquires Norwegian Immunoassay Start-Up SpinChip Diagnostics

bioMérieux (Marcy l’Étoile, France) has agreed to acquire SpinChip Diagnostics (Oslo, Norway), the developer of a game-changing immunoassay diagnostics platform. The small benchtop analyzer is well adapted... Read more
MEDLAB 2024
Copyright © 2000-2025 Globetech Media. All rights reserved.